His lab is focusing on refining the alanine-scanning assay to a few key residues which can accurately distinguish concerning fibrils from neurodegenerative tauopathies. He envisions employing this streamlined assay for postmortem neuropathological analysis, And perhaps for blood screening of tauopathies.They demonstrated this connection with equall